CRIM1, the Antagonist of BMPs, is a Potential Risk Factor of Cancer

E-ISSN： 1873-5576|14|7|652-658

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.7, 2014-09, pp. : 652-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of BMPs in Bone Anabolism and their Potential Targets SOST and DKK1

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-06 ,pp. : 153-163

Bentham Science Publishers

Access to resources Recommend Favorite

Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?

Current Drug Metabolism, Vol. 19, Iss. 11, 2018-09 ,pp. : 902-909

Bentham Science Publishers

Access to resources Recommend Favorite

Ochratoxin a: Its Cancer Risk and Potential for Exposure

By Clark Heather Snedeker Suzanne

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 9, Iss. 3, 2006-05 ,pp. : 265-296

Taylor & Francis Ltd

Access to resources Recommend Favorite

Scientific Rationale for Combination of a Calcium Channel Antagonist and an HMG-CoA Reductase Inhibitor: A New Approach to Risk Factor Management

By Mason R. Preston

Drugs, Vol. 68, Iss. 7, 2008-01 ,pp. : 885-900

Adis International

Access to resources Recommend Favorite

Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?

By Cancelli Iacopo Beltrame Massimiliano D'Anna Lucio Gigli Gian Luigi Valente Mariarosaria

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite